Evaluation of dermatological safety of test products by primary irritation patch test on healthy human volunteers of varied skin types

SilkLyfe0 个研究点目标入组 24 人开始时间: 待定最近更新: 2024年5月27日

试验速览

暂无简介。

•1. Healthy male and female subjects in the age group of 18 to 55 years (both age inclusive).
•2. Subjects with skin phototype III to V.
•3. Subjects representing normal, oily, dry and combination skin type in equal ratio.
•4. Subjects willing to give a voluntary written informed consent.
•5. Subjects willing to maintain the test patches in designated positions for 24 hours.
•6. Subjects willing to come for regular follow up visits.
•7. Subjects ready to follow instructions during the study period.
•8. Subjects without any open wounds, cuts, abrasions, and irritation symptoms.

•1. Subjects with known hypersensitivity to any of the study products or constituents.
•2. Subjects having any significant pathology in the test area.
•3. Subjects with any kind of skin allergy, antecedents/atopy or cutaneous disease which may influence the study results.
•4. Subjects having topical or systemic treatment that could interfere with the study treatments/assessments within the last 4 weeks prior to participation in the study and during the study.
•5. Athletes and subjects with history of excessive sweating.
•6. Subject is pregnant or lactating.
•7. Subjects with any significant medical condition that would interfere with the participation in the trial.
•8. Subjects participated in any other cosmetic or therapeutic trial or in a similar investigation in the past four weeks.

发起方

SilkLyfe